0JQ2.L

Kala Pharmaceuticals, Inc. [0JQ2.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

0JQ2.L Stock Summary

In the News

0JQ2.L Financial details

Company Rating
-
Market Cap
20.36M
Income
-46.42M
Revenue
0
Book val./share
4.4
Cash/share
21.98
Dividend
-
Dividend %
-
Employees
34
Optionable
No
Shortable
Yes
Earnings
01 Mar 2024
P/E
-0.42
Forward P/E
-
PEG
0.05
P/S
-
P/B
1.72
P/C
0.34
P/FCF
-0.59
Quick Ratio
5.45
Current Ratio
5.62
Debt / Equity
3.02
LT Debt / Equity
3.02
-
-
EPS (TTM)
-22.73
EPS next Y
-
EPS next Q
-
EPS this Y
-72.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-21.79%
-
-
-
-
SMA20
-8.38%
SMA50
-53.45%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-76%
ROE
-261%
ROC
-0.77%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
2.69M
Shs Float
2.12M
-
-
-
-
Target Price
-
52W Range
5.27-23.7453
52W High
-67.96%
52W Low
+47.4%
RSI
49.05
Rel Volume
0.05
Avg Volume
257
Volume
14
Perf Week
15.88%
Perf Month
-20.92%
Perf Quarter
-
Perf Half Y
-53.35%
-
-
-
-
Beta
-1.51
-
-
Volatility
1.01%, 0.95%
Prev Close
-3.03%
Price
7.37
Change
-8.67%

0JQ2.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
08.886.078.542.56
Net income per share
-124.73-137.89-99.59-108.32-29.48
Operating cash flow per share
-101.15-135.52-86.58-82.21-51.9
Free cash flow per share
-104.1-137.47-88.43-82.89-52.1
Cash per share
319.39125.91147.1570.6846.42
Book value per share
196.1943.495.4612.7612.48
Tangible book value per share
196.1943.495.4612.7612.48
Share holders equity per share
196.1943.495.4612.7612.48
Interest debt per share
131.24104.0468.9659.9524.95
Market cap
115.84M364.33M360.36M79.12M28.37M
Enterprise value
-55.05M278.88M283.09M-13.01M-42.13M
P/E ratio
-1.74-3.86-3.45-0.55-0.63
Price to sales ratio
059.9856.647.047.29
POCF ratio
-2.14-3.93-3.97-0.73-0.36
PFCF ratio
-2.08-3.87-3.89-0.73-0.36
P/B Ratio
1.112.273.64.711.5
PTB ratio
1.112.273.64.711.5
EV to sales
045.9144.5-1.16-10.82
Enterprise value over EBITDA
0.86-3.19-2.990.120.52
EV to operating cash flow
1.02-3.01-3.120.120.53
EV to free cash flow
0.99-2.97-3.060.120.53
Earnings yield
-0.58-0.26-0.29-1.8-1.58
Free cash flow yield
-0.48-0.26-0.26-1.38-2.79
Debt to equity
0.672.40.724.72
Debt to assets
0.320.460.330.570.44
Net debt to EBITDA
2.650.980.810.850.87
Current ratio
10.414.267.713.323.35
Interest coverage
00000
Income quality
0.810.980.870.761.76
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
04.492.883.394.54
Intangibles to total assets
00000
Capex to operating cash flow
0.030.010.020.010
Capex to revenue
0-0.22-0.31-0.08-0.08
Capex to depreciation
-1.65-1.58-2.13-0.91-0.58
Stock based compensation to revenue
01.642.091.431.8
Graham number
742.01366.94462.49176.3890.98
ROIC
-0.37-0.87-0.56-1.14-1.43
Return on tangible assets
-0.3-0.61-0.47-1.02-0.52
Graham Net
106.45-40.1740.43-10.441.89
Working capital
160.02M80.71M149.15M86.94M60.26M
Tangible asset value
104.98M29.69M100M16.8M18.97M
Net current asset value
61.04M-19.15M49.77M1.74M18.1M
Invested capital
0.672.40.724.72
Average receivables
15.78M10.58M12.47M7.77M
Average payables
3.32M3.98M2.12M3.31M3.87M
Average inventory
2.05M4.37M4.94M6.93M4.32M
Days sales outstanding
0694.85551498.318.29
Days payables outstanding
0457.7235.41436.45403.78
Days of inventory on hand
0844.88714.02769.640
Receivables turnover
00.530.660.7319.96
Payables turnover
00.81.550.840.9
Inventory turnover
00.430.510.472.56M
ROE
-0.64-3.18-1.04-8.49-2.36
Capex per share
-2.95-1.95-1.85-0.67-0.21

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.280000
Net income per share
19.25-7.97-6.99-4.36-3.41
Operating cash flow per share
-10.37-8.53-4.68-3.18-1.16
Free cash flow per share
-10.4-8.54-4.74-3.27-1.27
Cash per share
34.7943.8230.7724.7821.98
Book value per share
-0.6411.7811.357.334.4
Tangible book value per share
-0.6411.7811.357.334.4
Share holders equity per share
-0.6411.7811.357.334.4
Interest debt per share
28.2323.5516.0914.0613.28
Market cap
17.03M30.05M30.35M34.38M22.54M
Enterprise value
-35.36M-40.44M-33.28M-14.87M-33.52M
P/E ratio
0.15-0.58-0.52-0.83-0.65
Price to sales ratio
40.540000
POCF ratio
-1.09-2.19-3.13-4.53-7.64
PFCF ratio
-1.08-2.18-3.1-4.4-6.97
P/B Ratio
-17.591.581.291.972.01
PTB ratio
-17.591.581.291.972.01
EV to sales
-84.20000
Enterprise value over EBITDA
2.464.463.331.623.21
EV to operating cash flow
2.262.943.441.9611.35
EV to free cash flow
2.252.943.41.910.37
Earnings yield
1.71-0.43-0.48-0.3-0.39
Free cash flow yield
-0.92-0.46-0.32-0.23-0.14
Debt to equity
-44.0521.421.923.02
Debt to assets
0.50.440.460.50.55
Net debt to EBITDA
3.647.776.375.385.38
Current ratio
2.13.356.956.655.62
Interest coverage
00000
Income quality
-0.541.070.670.730.34
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
12.840000
Intangibles to total assets
00000
Capex to operating cash flow
000.010.030.1
Capex to revenue
-0.090000
Capex to depreciation
-0.25-0.28-1.4-2.78-3.56
Stock based compensation to revenue
3.160000
Graham number
16.6645.9742.2426.8118.38
ROIC
-0.35-0.16-0.18-0.18-0.23
Return on tangible assets
0.34-0.15-0.2-0.16-0.14
Graham Net
-22.51.787.234.32.45
Working capital
44.43M60.26M61.08M55.68M47.6M
Tangible asset value
-968K18.97M23.46M17.49M11.22M
Net current asset value
-1.99M18.1M22.58M16.53M8.01M
Invested capital
-44.0521.421.923.02
Average receivables
7.01M192.5K155K116K117K
Average payables
8.95M5.09M1.91M878.5K773.5K
Average inventory
12.5K1111
Days sales outstanding
40.710000
Days payables outstanding
60.12K0000
Days of inventory on hand
0.010000
Receivables turnover
2.210000
Payables turnover
00000
Inventory turnover
11K0000
ROE
-30.03-0.68-0.62-0.6-0.78
Capex per share
-0.03-0.01-0.05-0.09-0.11

0JQ2.L Frequently Asked Questions

What is Kala Pharmaceuticals, Inc. stock symbol ?

Kala Pharmaceuticals, Inc. is a US stock , located in Arlington of Ma and trading under the symbol 0JQ2.L

What is Kala Pharmaceuticals, Inc. stock quote today ?

Kala Pharmaceuticals, Inc. stock price is $7.37 today.

Is Kala Pharmaceuticals, Inc. stock public?

Yes, Kala Pharmaceuticals, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap